论文部分内容阅读
目的观察氟哌利多穴位注射对肺癌患者化疗反应的影响。方法将120例非小细胞肺癌患者随机分为3组,各40例,3组患者均采用相同的化疗方式,A组为氟哌利多注射液方案组,B组为对照组,C组为盐酸托烷司琼+氟哌利多注射液方案组,观察3组患者的消化道反应、血常规、肝及肾功能等。结果 3组恶性呕吐发生率差异有统计学意义(<0.05),其他各项发生率差异均无统计学意义(均>0.05)。A组与B组恶心呕吐发生率差异有统计学意义(<0.05);C组与B组恶心呕吐发生率差异有统计学意义(<0.05);C组与A组恶心呕吐发生率差异无统计学意义(>0.05)。结论氟哌利多穴位注射能改善肺癌患者恶心、呕吐等化疗反应,且能减少医疗卫生费用支出,值得推广。
Objective To observe the effect of droperidol injection on chemotherapy response in lung cancer patients. Methods A total of 120 patients with non-small cell lung cancer were randomly divided into 3 groups, 40 cases in each group. All patients in 3 groups were treated with the same chemotherapy. Group A was droperidol injection, group B was control, group C was hydrochloric acid Tropisetron + droperidol injection program group, observed three groups of patients with gastrointestinal reactions, blood, liver and kidney function. Results The incidence of malignant vomiting in the three groups was statistically significant (<0.05). There was no significant difference in other incidence rates (all> 0.05). There was a significant difference in the incidence of nausea and vomiting between group A and group B (<0.05). There was a significant difference in the incidence of nausea and vomiting between group C and group B (<0.05). There was no statistical difference in the incidence of nausea and vomiting between group C and group A Significance (> 0.05). Conclusions Droperidol injection can improve the response of patients with lung cancer to nausea, vomiting and other chemotherapy reactions, and can reduce medical expenses and is worth promoting.